[Recommendations for the treatment of heart failure : What's new?].

about

Effect of low-dose diuretics on the level of serum cystatin C and prognosis in patients with asymptomatic chronic heart failure.

P2860

Q36334710-38F6EAD4-6080-4CCB-BCAD-5042ABEC9399

P2860

[Recommendations for the treatment of heart failure : What's new?].

Item

http://www.wikidata.org/entity/Q44770065

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

[Recommendations for the treatment of heart failure : What's new?].

@en

[Recommendations for the treatment of heart failure : What's new?].

@nl

type

Item

label

[Recommendations for the treatment of heart failure : What's new?].

@en

[Recommendations for the treatment of heart failure : What's new?].

@nl

prefLabel

[Recommendations for the treatment of heart failure : What's new?].

@en

[Recommendations for the treatment of heart failure : What's new?].

@nl

P1476

[Recommendations for the treatment of heart failure : What's new?].

@en

P2093

F Edelmann

http://www.w3.org/2001/XMLSchema#string

G Hasenfuß

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON)

Increased mortality after dronedarone therapy for severe heart failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy.

Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.

P304

1141-1151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00108-013-3312-X

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rolf Wachter

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23860513

http://www.w3.org/2001/XMLSchema#string

[Recommendations for the treatment of heart failure : What's new?].

about

P2860

P2860

[Recommendations for the treatment of heart failure : What's new?].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698